HOME >> MEDICINE >> NEWS
Omega-3 fatty acids may slow cognitive decline in some patients with very mild Alzheimer's disease

Omega-3 fatty acid supplements may slow cognitive decline in some patients with very mild Alzheimer's disease, but do not appear to affect those with more advanced cases, according to results of a clinical trial published in the October issue of Archives of Neurology, one of the JAMA/Archives journals.

Alzheimer's disease is a severely debilitating condition that affects thinking, learning and memory, beginning with declines in episodic memory (including memory about events in one's own life), according to background information in the article. Medications are available to treat the symptoms, but these drugs do not affect the underlying cause and progression of the disease. Several studies have shown that eating fish, which is high in omega-3 fatty acids, may protect against Alzheimer's disease, leading researchers to question whether supplements could have similar effects.

Yvonne Freund-Levi, M.D., Karolinska Institutet, Stockholm, Sweden, and colleagues compared the effects of supplements containing two omega-3 fatty acids with placebo in 204 patients with Alzheimer's disease, 174 of whom completed the entire study. For six months, 89 patients (51 women and 38 men) took 1.7 grams of docosahexaenoic acid (DHA) and .6 grams of eicosapentaenoic acid (EPA), while 85 patients (39 women and 46 men) took placebo. For an additional six months, both groups took the omega-3 fatty acids. Patients had physical examinations, which included blood tests and blood pressure measurement, and took cognitive tests at the beginning of the study and at the six- and 12-month marks.

After six months, there was no difference in the rate of cognitive decline between the two groups. However, among a subgroup of 32 patients with very mild cognitive impairment at the beginning of the study, those who took the fatty acids experienced less decline in six months compared with those who took placebo. Among those who took placebo during the first six months, de
'"/>

Contact: Jan Palmblad
jan.palmblad@ki.se
JAMA and Archives Journals
9-Oct-2006


Page: 1 2

Related medicine news :

1. Omega-3 fatty acids may slow down early Alzheimers in some cases
2. The nude mouse tale: Omega-3 fats save the life of a terminal cancer patient
3. Omega-3 offers hope for new anti-breast cancer drugs
4. Can an omega-3 fatty acid slow the progression of Alzheimers disease?
5. Long-term effects of non-alcoholic fatty liver disease
6. Researchers estimate significant fatty liver disease in children
7. UCLA study shows altering fatty acid levels in diet may reduce prostate cancer growth rate
8. Patients with nonalcoholic fatty liver disease have an increased risk of heart disease
9. Omega 3 fatty acids influence mood, impulsivity and personality, study indicates
10. Consumption of omega-3 fatty acids unlikely to significantly reduce risk of cancer
11. Northwestern Memorial researchers aim to find answer to halting the progression of fatty liver

Post Your Comments:
(Date:5/22/2015)... May 22, 2015 In an effort ... and Sons is offering to donate $5 dollars for ... AC unit or water softening system. Customers have their ... and Sons gets business; and the Special Olympics receives ... Special Olympics helps over 4.4 million athletes, and boasts ...
(Date:5/22/2015)... In April 2006, Veatch Consulting opened for ... they have concentrated their focus to working with over ... of this growth and their goals to better serve ... Colorado, Cleveland, Ohio, Houston, Texas and now Dallas, Texas. ... offices, dental start ups, orthodontic practices, pediatric dental practices, ...
(Date:5/22/2015)... A new program for the "In ... field of Physical Therapy. , James Earl Jones ... out of physical therapy and discusses how the exercises ... a variety of ailments and injuries. Physical therapists ... plan that enhances daily activities such as house cleaning ...
(Date:5/22/2015)... Puritan Medical Products, a Maine manufacturer ... environmental, and forensics industries celebrates 96 years of ... US. At a time when countless manufacturing companies ... remains committed to designing and manufacturing their extensive ... , Since 1919, Puritan has focused on the ...
(Date:5/22/2015)... Yisrayl Hawkins, Pastor and Overseer at The ... letter calling on religious leaders to make changes in order ... on his blog, discusses the history of war, how it ... it. Yisrayl says mankind was created to lead peaceful, joyful ... society. , “Yahweh created mankind, according to His Plan, ...
Breaking Medicine News(10 mins):Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2
(Date:5/22/2015)... 2015 According to a new ... (Consumables, Instruments, Services), by Test Type (Indirect, Enzyme-based, Reactive ... by End Users - Global Forecast to 2020", published ... to reach $736.85 Million by 2020 from $452.36 Million ... Browse 71 market data Tables and 90 ...
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
(Date:5/22/2015)... Richmond Pharmacology is a ... a worldwide reputation for excellence in clinical trials. ... peer reviewed medical journals. Its officers are engaged ... discussions about rules for transparency and publication of ... , Clinical research is conducted worldwide, ...
Breaking Medicine Technology:Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
Cached News: